Ballentine Partners’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-4,771
| Closed | -$344K | – | 949 |
|
|
2024
Q4 | $344K | Buy |
4,771
+139
| +3% | +$10K | 0.01% | 546 |
|
|
2024
Q3 | $377K | Buy |
4,632
+741
| +19% | +$60.4K | 0.01% | 506 |
|
|
2024
Q2 | $289K | Sell |
3,891
-50
| -1% | -$3.71K | 0.01% | 574 |
|
|
2024
Q1 | $307K | Buy |
3,941
+273
| +7% | +$21.3K | 0.01% | 528 |
|
|
2023
Q4 | $262K | Buy |
+3,668
| New | +$262K | 0.01% | 542 |
|
|
2017
Q1 | – | Sell |
-6,222
| Closed | -$216K | – | 262 |
|
|
2016
Q4 | $216K | Sell |
6,222
-207
| -3% | -$7.19K | 0.02% | 169 |
|
|
2016
Q3 | $250K | Buy |
6,429
+219
| +4% | +$8.52K | 0.02% | 159 |
|
|
2016
Q2 | $215K | Buy |
6,210
+51
| +0.8% | +$1.77K | 0.02% | 196 |
|
|
2016
Q1 | $212K | Buy |
+6,159
| New | +$212K | 0.02% | 196 |
|